BioLegend Tools for iPad

Welcome to the BioLegend Tools for iPad application! Like our iPhone releases, this application provides you with important information about your mouse and human CD Molecules, Cytokines and Chemokines. It also includes BioLegend pathway posters, an antibody usage calculator, and a lab timer. What's more it is optimized for the iPad for speed and clarity. You can also find out all of the latest news and information about BioLegend including discounts and new products. Internet service is required for this application. BioLegend develops world-class, cutting-edge antibodies and reagents for biomedical research, offered at an outstanding value, manufactured in our state-of-the-art facility in San Diego, CA. Our product areas include cell immunophenotyping, cytokines and chemokines, adhesion, cancer research, T regulatory cells, stem cells, innate immunity, cell-cycle analysis, apoptosis, and modification-specific antibodies. All of BioLegend’s reagents are supported by superior customer service and come with a quality guarantee. Our aggressive product development program, through technology licensing, collaborations, and internal hybridoma development, produces strategic reagents for use in a variety of applications including flow cytometry, ELISA, immunoprecipitation, Western blotting, immunofluorescence microscopy, immunohistochemistry, and in vitro or in vivo functional assays. BioLegend offers the broadest selection of fluorochrome conjugates for multi-color flow cytometry. With an experienced biochemistry team, BioLegend is well positioned to offer a wide range of custom conjugation services to meet our customers’ specific needs. Incorporated in June 2002, BioLegend is located in San Diego, in the midst of one of the nation’s largest and fastest growing biotechnology clusters.

下载地址:iTunes 或者AAP STORE 下载

赞(0)
版权声明:本文采用知识共享 署名4.0国际许可协议 [BY-NC-SA] 进行授权
文章名称:《BioLegend Tools for iPad》
文章链接:https://www.skykkk.com/archives137197.html
本站资源仅供个人学习交流,请于下载后24小时内删除,不允许用于商业用途,否则法律问题自行承担。

相关推荐

  • 暂无文章